# ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial

> **NCT05686213** · PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 39 (estimated)

## Conditions studied

- Oncology

## Interventions

- **BEHAVIORAL:** combined aerobic exercise + resistance exercise intervention (AE + RE)
- **BEHAVIORAL:** Aerobic exercise prior to daily radiotherapy sessions (ExPR)

## Key facts

- **NCT ID:** NCT05686213
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686213, "ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05686213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*